Clinical Trial Update
Protein Transports Nutrients Believed to Protect Against Eye Disease
Nanoparticle Research in Review of Ophthalmology
Nanoparticles: Into the New Frontier
Pipex Sees Strong Data for Dry Age-Related Macular Degeneration Trial
Alcon Terminates the Development of Anecortave Acetate in Age-Related Macular Degeneration
Pipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Cl
Pipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Cl
Pipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Cl
A New Frontier in the Battle Against Disc Degeneration
A New Frontier in the Battle Against Disc Degeneration
Pipex Pharmaceuticals to Host Conference Call at 10:15am ET Wednesday July 9th to Discuss Phase II Clinical Tr
Shire to add new orphan drug to its HGT portfolio EU launch imminent
Shire to add new orphan drug to its HGT portfolio
New Oral Angiogenesis Inhibitor Offers Potential Nontoxic Therapy for a Wide Range of Cancers
Update: A 76-Year-Old Man With Macular Degeneration
Journal of the American Medical Association:
similar ...
Microscopic needles effectively deliver drugs to the eyes
Learn about the World Ophthalmic Pharmaceutical Drugs Market
Learn about the World Ophthalmic Pharmaceutical Drugs Market
Revolutionary Therapy: Needle-Free Technology for the Treatment of Blinding Eye Disease
